INGRESAR
CREAR CUENTA
Artículos
Cambios en la presentación, el tratamiento y los resultados | 23 AGO 21

Evolución de la gastrectomía por cáncer durante 30 años

Identificar qué áreas potenciales que pueden prestarse a mejoras adicionales y posible temas de investigación
Autor/a: Griffin SM, Kamarajah SK, Navidi M, Wahed S, Immanuel A, Hayes N, Phillips AW Surgery 2021; 170(1): 2-10
INDICE:  1. Texto principal | 2. Referencias bibliográficas
Referencias bibliográficas
  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66: 7e30.
  2. Russo A, Li P, Strong VE. Differences in the multimodal treatment of gastric cancer: East versus West. J Surg Oncol. 2017;115:603e614.
  3. Hartgrink HH, van de Velde CJH, Putter H, et al. Neo-adjuvant chemotherapy for operable gastric cancer: Long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol. 2004;30:643e649.
  4. Schuhmacher C, Gretschel S, Lordick F, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European organisation for research and treatment of cancer randomized trial 40954. J Clin Oncol. 2010;28:5210e5218.
  5. Songun I, Putter H, Kranenbarg EMK, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439e449.
  6. Degiuli M, Sasako M, Ponti A, et al. Morbidity and mortality after D2 gastrectomy for gastric cancer: Results of the Italian gastric cancer study group prospective multicenter surgical study. J Clin Oncol. 1998;16:1490e1493.
  7. Jiang L, Yang KH, Chen Y, et al. Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer. Br J Surg. 2014;101:595e604.
  8. Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg. 2014;101: 23e31.
  9. Wee IJY, Syn NLX, Shabbir A, et al. Enhanced recovery versus conventional care in gastric cancer surgery: A meta-analysis of randomized and non-randomized controlled trials. Gastric Cancer. 2019;22:423e434.
  10. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11e20.
  11. Navidi M, Madhavan A, Griffin SM, et al. Trainee performance in radical gastrectomy and its effect on outcomes. BJS Open. 2020;4:86e90.
  12. Mapstone N. Dataset for the Histopahtological Reporting of Oesophageal Carcinoma. 2nd ed. London, UK: Royal College of Pathologists; 2007.
  13. Grabsch H, Mapstone N, Novelli M. Standards and datasets for reporting cancers Dataset for histopathological reporting of oesophageal and gastric carcinoma. https://www.rcpath.org/uploads/assets/f8b1ea3d-5529-4f85-984c8d4d8556e0b7/g006-dataset-for-histopathological-reporting-of-oesophageal-and-gastric-carcinoma.pdf. Accessed January 2, 2021.
  14. Lagarde SM, Phillips AW, Navidi M, et al. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy. Dis Esophagus. 2017;30:1e7.
  15. Ajani J, In H, Sano T, Stomach. AJCC Cancer Staging Manual. In: Amin M, Edge S, Greene F, et al, eds. New York: Springer; 2016:203e220.
  16. Jung MR, Park YK, Seon JW, et al. Definition and classification of complications of gastrectomy for gastric cancer based on the accordion severity grading system. World J Surg. 2012;36:2400e2411.
  17. Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg. 2009;250:177e186.
  18. Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205e213.
  19. Kamarajah SK, Phillips AW, Hanna GB, Low DE, Markar SR, et al. Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma?: A Propensity-Matched Analysis. Annals of surgery. 2020. Ann Surg; 2020. https://doi.org/10.1097/SLA.0000000000004038.
  20. van der Werf LR, Busweiler LAD, van Sandick JW, et al. Reporting national outcomes after esophagectomy and gastrectomy according to the Esophageal Complications Consensus Group (ECCG). Ann Surg. 2020;271: 1095e1101.
  21. van Putten M, Nelen SD, Lemmens VEPP, et al. Overall survival before and after centralization of gastric cancer surgery in the Netherlands. Br J Surg. 2018;105: 1807e1815.
  22. Donohoe CL, Phillips AW, Flynn E, et al. Multimodal analgesia using intrathecal diamorphine, and paravertebral and rectus sheath catheters are as effective as thoracic epidural for analgesia post-open two-phase esophagectomy within an enhanced recovery program. Dis Esophagus. 2018;31.
  23. Ng Cheong Chung J, Kamarajah
« Página anterior
 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

CONTENIDOS RELACIONADOS
Mortalidad a los 90 días tras gastrectomía total por cáncer gástrico
» Centro de Atención IntraMed
AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024